Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners
1 2 3 4 5 6 7 8 9 10 ... Total pages:251  Next 

Life Science News

(China) Vitafoods Asia Strengthens its Position in the Nutraceutical Industry


(Press release, Vitafoods Asia)

29 September, 2014
Vitafoods Asia, the only Pan-Asian event dedicated exclusively to the nutraceutical industry, recently concluded its fourth edition on a high note, reinforcing its status as the definitive exhibition for the market.




Life Science News

(China) Epirus, Livzon Mabpharm enter deal for five biosimilar products in China


(Pharmaceutical-business-review.com)

26 September, 2014
US-based Epirus Biopharmaceuticals has signed a royalty-bearing, multi-product collaboration agreement with Livzon Mabpharm (Livzon), a Chinese biotechnology firm focused on the development, manufacture, and sale of antibody-based drugs.
More...




Life Science News

(China) Shares In Chinese Billionaire's Pharmaceuticals Maker Soar 15% On Acquisition


(Forbes)

28 September, 2014
Shares in Luye Pharmaceutical, a cancer drug maker led by Chinese billionaire Liu Dianbo, climbed by 15% at the Hong Kong Stock Exchange to a record high today after the company announced plans to buy a majority stake in Beijing Jialin Pharmaceutical.
More...




Life Science News

(Taiwan) NHI to stop covering repackaged drugs from next year


(Taipei Times)

24 September, 2014
The National Health Insurance (NHI) program is to stop covering repackaged drugs next year in a bid to improve medication safety, the NHI Administration said yesterday.
More...




Life Science News

(Taiwan) GeneReach profit soars on orders from new clients


(Taipei Times)

18 September, 2014
GeneReach Biotechnology Corp yesterday reported a 6.5-fold increase in profit last month due to rising orders from new clients. The Greater Taichung-based firm makes disease detection devices and reagents for pets, livestock and the aquaculture industry.
More...




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part four)


(By Dave Silver, BiotechEast)

(Part four of a four-part series)

10 July, 2014
Synergies, compatibilities and opportunities

A: Synergies in specific therapeutic areas
There are interesting similarities in the research expertise in both countries, setting up synergies that can only encourage closer collaborations. For example, research into cancer therapeutics is the focus of both countries, as is immunology. And the intersection of the two in the exciting new field of cancer immunotherapy is another where the two countries have world-class scientists, discovery and development taking place.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part three)


(By Dave Silver, BiotechEast)

(Part three of a four-part series)

10 July, 2014
New funding initiatives to boost number and strength of startups
Perhaps the biggest hurdle standing in the way of success for New Zealand’s burgeoning bioscience sector, both for startups and ones who’ve been around for longer, is the lack of access to sufficient funding. New Zealand’s local VC industry is relatively inexperienced and risk averse, and funding that does become available through such channels is often insufficient. And going public in New Zealand (or Australia, its closest neighbor) is not the same money-raising exercise it can be in countries with larger populations and capital markets. As a result, New Zealand biotech startups stay relatively small and underfunded and with pipelines a little too shallow; growth potential is being held back as a result.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part two)


(By Dave Silver, BiotechEast)

(Part two of a four-part series)

10 July, 2014
New Zealand's strengths in drug discovery a good fit for Taiwan
The business model underpinning the biotechnology industry is the value chain, where a piece of intellectual property–such as a new drug molecule–changes hands as it moves along the chain, undergoing development and gaining value at each step along the way until it reaches the market. And for small countries such as New Zealand and Taiwan and in particular when it comes to drug development, success depends on finding a niche position in the chain where value can be captured and added to before passing it on to the next player.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part one)


(By Dave Silver, BiotechEast)

(Part one of a four-part series)

10 July, 2014
With the catalyst that was the signing on December 1, 2013 of ANZTEC* a free trade agreement between New Zealand and Taiwan and the first signed between Taiwan and an OECD economy, two-way trade between the two countries is already up over 30 percent. While there are opportunities across the spectrum of goods and services, it’s biotechnology that may be best placed to take advantage of this agreement. With complementary capabilities, and coupled with the fact that both are small countries with innovative and entrepreneurial drive in their collective DNA, New Zealand and Taiwan have already begun forging collaborations that could significantly boost the bio-industries of both countries.




Life Science News

(Taiwan) GNT of Taiwan and Penderyn Distillery of Wales launch gold flake whisky for sale in Taiwan and China


(BiotechEast staff)

2 September, 2014
Taiwan's Gold NanoTech Inc. (GNT) and Penderyn Distillery, Wales' only distillery, have teamed up to produce a special product to be sold in Taiwan and China; Penderyn Welsh single malt whisky laced with edible gold flakes. The two companies will hold a ceremony on the distillery premises on Tuesday, signing a Memorandum of Understanding (MOU) agreement to formalize their cooperation.




Sponsors

Events



Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy